Paxlovid Treatment Guidelines

Important Considerations

• Ritonavir is a strong CYP3A inhibitor and perpetrator of many drug-drug interactions, and it is recommended to always check for drug interactions before prescribing Paxlovid using resources like the Liverpool COVID-19 Drug Interaction Tool 1
• High-risk interactions to avoid include antiarrhythmics, certain anticoagulants, and some statins, as they can have significant interactions with Paxlovid 1
• The duration of interaction risk extends beyond the 5-day treatment period due to ritonavir's effects on metabolism and clearance 1
• Dysgeusia and diarrhea are common adverse effects of Paxlovid, and patients should be monitored for potential hepatotoxicity 1
• Paxlovid has shown significant efficacy in reducing hospitalization and death in high-risk patients with COVID-19 when administered within 5 days of symptom onset 2